In vitro fungicidal photodynamic effect of hypericin on candida species

Photochemistry and Photobiology

Volumn 88, Issue 3, 2012, Pages 613-619

  Rezusta, Antonio ^a,b   Lõpez Chicõn, Patricia ^c   Paz Cristobal, Manuel P ^b   Alemany Ribes, Mireia ^c   Royo Díez, David ^b   Agut, Montserrat ^c   Semino, Carlos ^c   Nonell, Santi ^c   Revillo, Ma Jose ^a   Aspiroz, Carmen ^b,d   Gilaberte, Yolanda ^b,e  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c Institut Químic de Sarrià Universitat Ramon Llull   (Spain)

^d HOSPITAL ROYO VILLANOVA   (Spain)

^e HOSPITAL SAN JORGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DRUG DERIVATIVE; HYPERICIN; PERYLENE; PHOTOSENSITIZING AGENT;

ARTICLE; CANDIDA; CELL CULTURE; CLASSIFICATION; DRUG EFFECT; HUMAN; IN VITRO STUDY; MICROBIOLOGICAL EXAMINATION; PHOTOCHEMOTHERAPY; SPECIES DIFFERENCE;

ANTIFUNGAL AGENTS; CANDIDA; CELLS, CULTURED; HUMANS; MICROBIAL SENSITIVITY TESTS; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SPECIES SPECIFICITY;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ISSATCHENKIA ORIENTALIS;

EID: 84860657420     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2011.01053.x     Document Type: Article

References (47)

1. Rex, J., T. Walsh, J. Sobel, S. Filler, P. Pappas, W. Dismukes, and, J. Edwards, (2000) Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin. Infect. Dis. 30, 662-678.
2. Lasker, B., C. Elie, T. Lott, A. Espinel-Ingroff, L. Gallagher, R. Kuykendall, M. Kellum, W. Pruitt, D. Warnock, D. Rimland, M. McNeil, and, E. Reiss, (2001) Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits. Med. Mycol. 39, 341-352.
3. Vazquez, J., (2003) Invasive oesophageal candidiasis: Current and developing treatment options. Drugs 63, 971-989.
4. Almirante, B., D. Rodríguez, B. Park, M. Cuenca-Estrella, A. Planes, M. Almela, J. Mensa, F. Sanchez, J. Ayats, M. Gimenez, P. Saballs, S. Fridkin, J. Morgan, J. Rodriguez-Tudela, D. Warnock, A. Pahissa, and, B. C. P. S. Group, (2005) Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 43, 1829-1835.
5. Pfaller, M., D. Diekema, R. Jones, H. Sader, A. Fluit, R. Hollis, S. Messer, and, S. P. Group, (2001) International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39, 3254-3259.
6. Vazquez, J., M. Lynch, and, J. Sobel, (1995) In vitro activity of a new pneumocandin antifungal agent, L-733,560 against azole-susceptible and -resistant Candida and Torulopsis species. Antimicrob. Agents Chemother. 39, 2689-2691.
7. Yoon, S., J. Vazquez, P. Steffan, J. Sobel, and, R. Akins, (1999) High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob. Agents Chemother. 43, 836-845.
8. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and, Q. Peng, (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889-905.
9. Jori, G., C. Fabris, M. Soncin, S. Ferro, O. Coppellotti, D. Dei, L. Fantetti, G. Chiti, and, G. Roncucci, (2006) Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg. Med. 38, 468-481.
10. Wustrow, T., (1995) Mechanisms of phototoxic effects in photodynamic therapy. Adv. Otorhinolaryngol. 49, 31-35.
11. Donnelly, R., P. McCarron, and, M. Tunney, (2008) Antifungal photodynamic therapy. Microbiol. Res. 163, 1-12.
12. Sharma, S. K., T. Dai, G. B. Kharkwal, Y. Y. Huang, L. Huang, V. J. De Arce, G. P. Tegos, and, M. R. Hamblin, (2011) Drug discovery of antimicrobial photosensitizers using animal models. Curr. Pharm. Des. 17, 1303-1319.
13. Demidova, T., and, M. Hamblin, (2004) Photodynamic therapy targeted to pathogens. Int. J. Immunopathol. Pharmacol. 17, 245-254.
14. Jackson, Z., S. Meghji, A. MacRobert, B. Henderson, and, M. Wilson, (1999) Killing of the yeast and hyphal forms of Candida albicans using a light-activated antimicrobial. Lasers Med. Sci. 14, 150-157.
15. Monfrecola, G., E. Procaccini, M. Bevilacqua, A. Manco, G. Calabro, and, P. Santoianni, (2004) In vitro effect of 5-aminolaevulinic acid plus visible light on Candida albicans. Photochem. Photobiol. Sci. 3, 419-422.
16. Paardekooper, M., A. De Bruijne, A. Van Gompel, R. Verhage, D. Averbeck, T. Dubbelman, and, P. Van den Broek, (1997) Single strand breaks and mutagenesis in yeast induced by photodynamic treatment with chloroaluminum phthalocyanine. J. Photochem. Photobiol. B: Biol. 40, 132-140.
17. Souza, R., J. Junqueira, R. Rossoni, C. Pereira, E. Munin, and, A. Jorge, (2009) Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against Candida albicans. Lasers Med. Sci. 25, 385-389.
18. Calzavara-Pinton, P., M. Venturini, and, R. Sala, (2005) A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J. Photochem. Photobiol. B: Biol. 78, 1-6.
19. Soukos, N., L. Ximenez-Fyvie, M. Hamblin, S. Socransky, and, T. Hasan, (1998) Targeted antimicrobial photochemotherapy. Antimicrob. Agents Chemother. 42, 2595-2601.
20. Zeina, B., J. Greenman, W. Purcell, and, B. Das, (2001) Killing of cutaneous microbial species by photodynamic therapy. Br. J. Dermatol. 144, 274-278.
21. Durán, N., and, P. Song, (1986) Hypericin and its photodynamic action. Photochem. Photobiol. 43, 677-680.
22. Kiesslich, T., B. Krammer, and, K. Plaetzer, (2006) Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr. Med. Chem. 13, 2189-2204.
23. Kubin, A., P. Meissner, F. Wierrani, U. Burner, A. Bodenteich, A. Pytel, and, N. Schmeller, (2008) Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin. Photochem. Photobiol. 84, 1560-1563.
24. Sgarbossa, A., D. Buselli, and, F. Lenci, (2008) In vitro perturbation of aggregation processes in beta-amyloid peptides: A spectroscopic study. FEBS Lett. 582, 3288-3292.
25. Olivo, M., W. Lau, V. Manivasager, R. Bhuvaneswari, Z. Wei, K. Soo, C. Cheng, and, P. Tan, (2003) Novel photodynamic diagnosis of bladder cancer: Ex vivo fluorescence cytology using hypericin. Int. J. Oncol. 23, 1501-1504.
26. Olivo, M., H. Du, and, B. Bay, (2006) Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy. Curr. Clin. Pharmacol. 1, 217-222.
27. Kacerovská, D., K. Pizinger, F. Majer, and, F. Smíd, (2008) Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract - a pilot study. Photochem. Photobiol. 84, 779-785.
28. Rook, A. H., G. S. Wood, M. Duvic, E. C. Vonderheid, A. Tobia, and, B. Cabana, (2010) A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis. J. Am. Acad. Dermatol. 63, 984-990.
29. Pistelli, L., A. Bertoli, S. Zucconelli, I. Morelli, L. Panizzi, and, F. Menichini, (2000) Antimicrobial activity of crude extracts and pure compounds of Hypericum hircinum. Fitoterapia 71 (Suppl. 1), S138-S140.
30. Lavie, G., Y. Mazur, D. Lavie, A. Prince, D. Pascual, L. Liebes, B. Levin, and, D. Meruelo, (1995) Hypericin as an inactivator of infectious viruses in blood components. Transfusion 35, 392-400.
31. Sorrell, J. M., and, A. I. Caplan, (2009) Fibroblasts-a diverse population at the center of it all. Int. Rev. Cell. Mol. Biol. 276, 161-214.
32. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and, D. C. Klenk, (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
33. Pagonis, T. C., J. Chen, C. R. Fontana, H. Devalapally, K. Ruggiero, X. Song, F. Foschi, J. Dunham, Z. Skobe, H. Yamazaki, R. Kent, A. C. Tanner, M. M. Amiji, and, N. S. Soukos, (2010) Nanoparticle-based endodontic antimicrobial photodynamic therapy. J. Endod. 36, 322-328.
34. Ernst, E., K. Yodoi, E. Roling, and, M. Klepser, (2002) Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods. Antimicrob. Agents Chemother. 46, 578-581.
35. So, C., P. Tsang, P. Lo, C. Seneviratne, L. Samaranayake, and, W. Fong, (2010) Photodynamic inactivation of Candida albicans by BAM-SiPc. Mycoses 53, 215-220.
36. Dovigo, L., A. Pavarina, E. de Oliveira Mima, E. Giampaolo, C. Vergani, and, V. Bagnato, (2009) Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 54, 123-130.
37. Moghissi, K., (2010) Can Surgical Site Infection (SSI) be treated by photodynamic therapy (PDT)? Photodiagnosis Photodyn. Ther. 7, 1-2.
38. Tanaka, M., M. Kinoshita, Y. Yoshihara, N. Shinomiya, S. Seki, K. Nemoto, T. Hirayama, T. Dai, L. Huang, M. R. Hamblin, and, Y. Morimoto, (2011) Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem. Photobiol. DOI:.
39. Nishiuchi, T., T. Utsumi, T. Kanno, Y. Takehara, H. Kobuchi, T. Yoshioka, A. A. Horton, T. Yasuda, and, K. Utsumi, (1995) Inhibition of neutrophil superoxide generation by hypericin, an antiretroviral agent. Arch. Biochem. Biophys. 323, 335-342.
40. Bliss, J. M., C. E. Bigelow, T. H. Foster, and, C. G. Haidaris, (2004) Susceptibility of Candida Species to photodynamic effects of Photofrin. Antimicrob. Agents Chemother. 48, 2000-2006.
41. Espinel-Ingroff, A., M. Pfaller, S. A. Messer, C. C. Knapp, N. Holliday, and, S. B. Killian, (2004) Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J. Clin. Microbiol. 42, 718-721.
42. Ho, Y. F., M. H. Wu, B. H. Cheng, Y. W. Chen, and, M. C. Shih, (2009) Lipid-mediated preferential localization of hypericin in lipid membranes. Biochim. Biophys. Acta 1788, 1287-95.
43. Mikeš, J., M. Hãžäalová, L. Kočí, R. Jendželovskã, J. Kovaä, A. Vaculová, J. Hofmanová, A. Kozubík, and, P. Fedoročko, (2011) Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin. Photochem. Photobiol. Sci. 10, 626-632.
44. Cormick, M., M. Alvarez, M. Rovera, and, E. Durantini, (2009) Photodynamic inactivation of Candida albicans sensitized by tri- and tetra-cationic porphyrin derivatives. Eur. J. Med. Chem. 44, 1592-1599.
45. Lam, M., P. C. Jou, A. A. Lattif, Y. Lee, C. L. Malbasa, P. K. Mukherjee, N. L. Oleinick, M. A. Ghannoum, K. D. Cooper, and, E. D. Baron, (2011) Photodynamic therapy with Pc 4 induces apoptosis of Candida albicans. Photochem. Photobiol. 87, 904-909.
46. Lambrechts, S., M. Aalders, and, J. Van Marle, (2005) Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphyrin. Antimicrob. Agents Chemother. 49, 2026-2034.
47. Carvalho, G., M. Felipe, and, M. Costa, (2009) The photodynamic effect of methylene blue and toluidine blue on Candida albicans is dependent on medium conditions. J. Microbiol. 47, 619-623.